Skip to main content

Find Clinical Trials

Clinical trial condition

ADHD

Explore clinical trials studying ADHD. Study availability and eligibility vary by location and protocol.

409 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

ADHD trial results

Completed

Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

NCT00315276

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
Locations: Neurology Clinical Study Centers, LLC Little Rock, Arkansas, United States

Bay Area Research Institute Lafayette, California, United States

Pharmacology Research Institute Northridge, California, United States

Peninsula Research Associates Rolling Hills Estates, California, United States

View all 18 locations

View Trial Details

Completed

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

NCT00214981

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations: University of Alabama Birmingh Birmingham, Alabama, United States

Pivotal Research Center Mesa, Arizona, United States

River Valley Neurology Fort Smith, Arkansas, United States

Clinical Study Centers, LLC Little Rock, Arkansas, United States

View all 57 locations

View Trial Details

Completed

Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

NCT00586573

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Massachusetts General Hospital Cambridge, Massachusetts, United States

View Trial Details

Completed

Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta

NCT00181792

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations: Massachusetts General Hospital Cambridge, Massachusetts, United States

View Trial Details

Completed

Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)

NCT01243242

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Cognitive Neurology unit Rambam Health Care Campus Haifa, Israel

ADHD Unit, Geha Mental Health Center Petah Tikva, Israel

View Trial Details

Completed

The Reinforcing Mechanisms of Smoking in Adult ADHD

NCT00573859

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations: Department of Pediatrics Irvine, California, United States

View Trial Details

Completed

Nicotine and Behavior in Adult ADHD

NCT00573248

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +5 more
Locations: Department of Pediatrics Irvine, California, United States

View Trial Details

Completed

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

NCT00364702

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Shaari Zedek Pediatric Neurology Unit Jerusalem, Israel

View Trial Details

Completed

Social Skills Training and Standard Treatment Versus Standard Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00937469

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
Locations: Børnepsykiatrisk Ambulatorium, Børne- og Ungdomspsykiatrisk Afdeling, Region Sjælland Holbæk, Denmark

View Trial Details

Completed

A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00429091

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations: Site Reference ID/Investigator# 5965 San Francisco, California, United States

Site Reference ID/Investigator# 5955 Wildomar, California, United States

Site Reference ID/Investigator# 5974 Orlando, Florida, United States

Site Reference ID/Investigator# 5956 West Palm Beach, Florida, United States

View all 22 locations

View Trial Details